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Three distinct ypes of protein kinase C obtained from rat brain cytosol phosphorylated the EGF receptor 
of A431 epidermoid carcinoma cells at different rates. This receptor was phosphorylated most rapidly by 
type III protein kinase C, but slowly by type I enzyme. Type II enzyme showed intermediate activity. Chro- 
matographic analysis indicated that A431 cells possessed only one of the three types found in rat brain, 
which apparently corresponded to type III enzyme. This type of protein kinase C, that is encoded by the 
~t-sequence or a closely related sequence, appeared to be expressed commonly in many tissues and organs. 
The result implies that type III enzyme may play roles in growth promotion. 
Protein kinase C; EGF receptor; (A431 epidermoid carcinoma cell) 
1. INTRODUCTION 
The EGF receptor has been repeatedly shown to 
be phosphorylated by protein kinase C, resulting in 
the desensitization or down-regulation of this 
receptor function [1-6]. Recent analysis of cDNA 
clones has indicated that there are at least four 
subspecies of protein kinase C, namely ce, f I ,  BII 
and 7, which have similar structures [7-10]. In ad- 
dition, protein kinase C in rat brain can be 
separated into three fractions, type I, II and II I ,  by 
hydroxyapatite column chromatography [11-13]. 
Expression of each of the rat brain cDNA clones in 
COS cells shows that ce, flI and f l I ,  and 7 clones 
correspond to type II I ,  II, and I protein kinase C, 
respectively [12,13]. The two subspecies having the 
f I -  and fill-sequence are derived from alternative 
splicing from a single gene, and are in- 
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distinguishable chromatographically from each 
other [12]. The three types of protein kinase C 
show slightly different kinetic properties. To ex- 
plore the functional difference of these protein 
kinase subspecies, the EGF receptor of A431 
epidermoid carcinoma cells was employed as a test 
substrate for comparison of the three distinct 
types. A431 cells contain only the type I I I  enzyme 
having probably the a-sequence or a closely related 
sequence. 
2. MATERIALS AND METHODS 
2.1. Assay and purification of  protein kinase C 
The enzyme was routinely assayed with calf 
thymus H1 histone as a substrate [14]. A mixture 
of the multiple forms of protein kinase C was 
purified from rat brain cytosol by DE-52 column 
chromatography, followed by a threonine- 
Sepharose column and a TSK phenyl-5PW column 
connected to a high-performance liquid 
chromatography (HPLC) system as described [14]. 
This apparently homogeneous preparation was 
resolved further into three fractions, type I, II and 
I I I ,  by chromatography on a hydroxyapatite col- 
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umn connected to HPLC [12,13]. Each of the three 
fractions showed an apparently single band upon 
SDS-polyacrylamide gel electrophoresis, and the 
specific activities of these enzymes were practically 
identical. The three types of enzyme phos- 
phorylated the same sites of H1 histone as judged 
by tryptic peptide analysis. Other procedures are 
indicated for each experiment. 
2.2. EGF receptor phosphorylation 
A431 cells were cultured in Dulbecco's modified 
Eagle's medium containing 10°70 fetal calf serum. 
The membrane fraction of A431 cells was prepared 
as described by Cohen et al. [15], and stored in 
10 mM Hepes buffer at -80°C.  The membrane 
proteins were phosphorylated by protein kinase C 
as described by Cochet et al. [1]. The reaction mix- 
ture (60/zl) contained 20 mM Hepes buffer at pH 
7.2, 10mM MgC12, 0.5 mM Na3VO4, 2/zM 
[y-32PIATP (8300 cpm/pmol),  60/zg/ml of 
phosphatidylserine, 6/zg/ml of diolein, 27/zg of 
A431 membrane protein, and each type of protein 
kinase C (0.25 units). One unit of protein kinase C 
was defined as that amount of enzyme which 
transferred 1 nmol Pi from [y-3zp]ATP into H1 
histone per rain under the stated conditions. After 
incubation for 5 min at 30°C, the reaction was ter- 
minated by the addition of Laemmli sample buffer 
[16] or RIPA buffer [17]. The phosphorylated 
EGF receptor in RIPA buffer was precipitated by 
incubation with 10 #g/ml  of an anti-EGF receptor 
monoclonal antibody (Amersham) for 1 h, and 
then with a sufficient volume of protein A- 
Sepharose (Pharmacia), for an additional 1 h at 
4°C. After washing several times with RIPA buf- 
fer, Laemmli sample buffer was added to the 
suspension of protein A-Sepharose. The samples in 
Laemmli sample buffer were boiled for 2 min, and 
subjected to electrophoresis on a 7.5% SDS- 
polyacrylamide gel. After staining with Coomassie 
blue, the gel was dried and exposed to an X-ray 
film with intensifying screen at - 80°C. The absor- 
bance of autoradiography was traced at 430 nm. 
Autophosphorylation f the EGF receptor was 
carried out as described by Carpenter et al. [18]. 
The reaction mixture (50/A), containing 27/tg 
A431 membrane protein, 20 mM Hepes buffer at 
pH 7.4, 1 mM MnCI2, and 100 nM EGF, was 
preincubated for 10 min at 0°C. After the addition 
of 15/tM [7-32p]ATP (1300 cpm/pmol),  the mix- 
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ture was incubated for a further 10 min at 0°C. 
The reaction was then stopped by Laemmli sample 
buffer. 
3. RESULTS AND DISCUSSION 
The three types of protein kinase C were capable 
of phosphorylating several proteins associated 
with A431 cell membranes. In particular, EGF 
receptor proteins of 170 and 150 kDa as well as a 
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Fig. 1. Protein phosphorylation in A431 cell membrane. 
A431 membrane proteins were phosphorylated byeach 
type of rat brain protein kinase C or by EGF, and 
analyzed by SDS-polyacrylamide gel electrophoresis 
followed by autoradiography as described in section 2. 
Numbers with arrows indicate the molecular mass 
markers (K, kDa): myosin heavy chain (200 kDa), /5'- 
galactosidase (l l6kDa), phosphorylase b (98kDa), 
bovine serum albumin (66 kDa), and ovalbumin 
(45 kDa). (A) Protein phosphorylation i A431 cell 
membrane by three types of protein kinase C. Lanes: 
(1,2) A431 cell membrane alone; (3,4) plus type I protein 
kinase C; (5,6) plus type II protein kinase C; (7,8) plus 
type III protein kinase C; (1,3,5,7) with 1 mM EGTA 
and without lipid; (2,4,6,8) with 0.5 mM CaClz, 
60/zg/ml phosphatidylserine, and 6 ~g/ml diolein. The 
three closed arrowheads indicate 170 kDa and 150 kDa 
EGF receptor, and 70 kDa functionally unknown 
protein. The open arrowhead indicates protein kinase C. 
(B) Immunoprecipitation a d autophosphorylation of 
the EGF receptor. A431 membrane was phosphorylated 
by type III protein kinase C and immunoprecipitated 
(lanes 1,2). In another set of experiments A431 
membrane was incubated with or without EGF in the 
absence of exogenous protein kinase C (auto- 
phosphorylation) (lanes 3,4). Detailed conditions are 
given in section 2. Lanes: (1) EGF receptor immuno- 
precipitated from the sample shown in lane 2; (2) A431 
membrane phosphorylated bytype III protein kinase C; 
(3) A431 membrane incubated without EGF; (4) A431 
membrane incubated with EGF. 
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protein of 70 kDa were phosphorylated most 
predominantly by type III enzyme as indicated by 
closed arrowheads in fig.lA. The function of the 
70 kDa protein is unknown, but this protein 
phosphorylation has been described previously by 
Cochet et al. [1]. These proteins were 
phosphorylated by type I enzyme slowly, and by 
type II enzyme in an intermediate fashion. Con- 
versely, autophosphorylation f the enzyme was 
most predominant for type I enzyme as shown by 
an open arrowhead. There was no indication that 
the different rates of autophosphorylation were 
due to the different amounts of preexisting 
phosphate that may have been attached to the en- 
zyme molecules when initially purified. These 
results are shown more quantitatively in fig.2. All 
phosphorylation reactions were dependent on 
Ca 2÷, diacylglycerol, and phosphatidylserine. It is 
unlikely that the three types of enzyme 
phosphorylated different sites of the EGF recep- 
tor, since brain protein kinase C was previously 
shown to phosphorylate only one threonine 
residue, Thr-654 [1,19,20]. 
The identity of the radioactive EGF receptor was 
determined from the experiments given in fig.lB. 
The two proteins were precipitated by an anti-EGF 
receptor monoclonal antibody (fig.lB, lanes 1,2). 
Autophosphorylation f EGF receptor molecules 
was greatly enhanced by the addition of EGF 
(fig.lB, lanes 3,4). It has been described by Cohen 
et al. [15] that the 150 kDa protein is a partially 
digested form of the 170 kDa intact EGF receptor. 
In a separate set of experiments given in fig.3, it 
was shown that A431 cells possess only one type of 
protein kinase C that was eluted in the fraction 
similar to type III rat brain enzyme, when 
chromatographed on a hydroxyapatite column. 
Since the brain type III enzyme is known to be en- 
coded by the or-sequence [13], A431 cell protein 
kinase C probably has the or-sequence or a closely 
related structure. This type of protein kinase C is 
found most commonly in many tissues and organs. 
It has been reported that the EGF receptor of in- 
tact cells is phosphorylated by stimulation with 
tumor-promoting phorbol ester, which is a potent 
activator of protein kinase C [1-6]. EGF receptor 
phosphorylation by this enzyme was subsequently 
shown to be related to the down-regulation of the 
receptor [1-6]. In the present studies, it remains 
unproven whether the observed modification of 
the integral membrane proteins by exogenously 
added protein kinase C results directly in the func- 
tional alteration of the receptor. Nevertheless, type 
III enzyme, commonly present in many tissues in- 
cluding A431 cells, is most likely to be responsible 
for EGF receptor phosphorylation. 
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Fig.2. Densitometric tracing of autoradiograph s own in fig. IA. A, B and C; lanes 3, 5 and 7 in fig. IA, respectively. 
(a) Protein kinase C, (b) EGF receptors. 
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Fig.3. Hydroxyapatite column chromatography of 
protein kinase C. Protein kinase C from the cytosol of 
A431 cells (4 x 108) was purified by TSK DEAE-5PW 
column chromatography under conditions similar to 
those employed for the rat brain enzyme [14], and 
subjected to the hydroxyapatite column. Rat brain 
protein kinase C was purified as described in section 2. 
(A) A431 cell protein kinase C, (B) rat brain protein 
kinase C. (¢. ~) Protein kinase activity in the 
presence of 8#g/ml phosphatidylserine, 0.8#g/ml 
diolein, and 0.5 mM CaClz; (o ©) protein kinase 
activity in the presence of 1 mM EGTA instead of 
phosphatidylserine, diolein, and CaCI2; ( ) buffered 
potassium phosphate. 
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